Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Other Non Operating Income (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Other Non Operating Income for 4 consecutive years, with -$5000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income fell 110.2% to -$5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$189000.0 through Dec 2025, down 2262.5% year-over-year, with the annual reading at -$190000.0 for FY2025, 2275.0% down from the prior year.
  • Other Non Operating Income for Q4 2025 was -$5000.0 at Phathom Pharmaceuticals, up from -$7000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $49000.0 in Q4 2024, with the low at -$197000.0 in Q3 2023.
  • Average Other Non Operating Income over 4 years is -$30937.5, with a median of -$7500.0 recorded in 2022.
  • The sharpest move saw Other Non Operating Income soared 450.0% in 2024, then crashed 2483.33% in 2025.
  • Over 4 years, Other Non Operating Income stood at -$90000.0 in 2022, then surged by 84.44% to -$14000.0 in 2023, then skyrocketed by 450.0% to $49000.0 in 2024, then crashed by 110.2% to -$5000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$5000.0, -$7000.0, and -$155000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.